Managing Hypotension in Heart Failure Patients

Initial Assessment and Management

• The American College of Cardiology recommends determining if a patient has signs of hypoperfusion, which requires immediate intervention, in patients with heart failure and hypotension, with a focus on decreasing urine output, altered mental status, and cool extremities 1, 3
• Assessing for elevated cardiac filling pressures, such as elevated jugular venous pressure and pulmonary congestion, is crucial to guide fluid management decisions in heart failure patients with hypotension, according to the American College of Cardiology 2, 4
• The American Heart Association suggests considering invasive hemodynamic monitoring if the adequacy of intracardiac filling pressures cannot be determined from clinical assessment in patients with heart failure and hypotension 3, 4
• Identifying and treating potential underlying causes of hypotension, including acute coronary syndromes, arrhythmias, infections, pulmonary emboli, renal failure, or medication non-compliance, is essential in managing heart failure patients with hypotension, as recommended by the American College of Cardiology 1, 2

Management Algorithm Based on Clinical Presentation

• The European Society of Cardiology recommends temporarily holding or reducing doses of blood pressure-lowering medications not essential for heart failure treatment, such as calcium channel blockers and alpha-blockers, in patients with heart failure and hypotension 5
• The American College of Cardiology suggests considering temporarily reducing doses of ACE inhibitors/ARBs and beta-blockers if severe hypotension persists despite other measures in heart failure patients, with a focus on maintaining optimal blood pressure control 6
• The European Heart Journal recommends against abruptly discontinuing beta-blockers, as this can worsen cardiac function in patients with heart failure and hypotension 6

Special Considerations

• The European Journal of Heart Failure notes that orthostatic hypotension is common in heart failure patients, with a prevalence of 8-83%, and may contribute to symptomatic hypotension, highlighting the need for careful monitoring and management 8
• Monitoring for electrolyte abnormalities, particularly with diuretic therapy, is crucial, as they can worsen hypotension in heart failure patients, according to the European Journal of Heart Failure 8
• The European Journal of Heart Failure recommends starting at lower doses and titrating more slowly than usual when initiating or titrating heart failure medications in patients with baseline low blood pressure 9

Monitoring and Follow-up

• The American College of Cardiology recommends closely monitoring vital signs, urine output, mental status, and peripheral perfusion in patients with heart failure and hypotension 4
• The American Heart Association suggests performing daily measurements of electrolytes, BUN, and creatinine during active treatment of heart failure patients with hypotension 1, 3

Pitfalls to Avoid

• The American College of Cardiology recommends avoiding the administration of calcium channel blockers, particularly non-dihydropyridines like diltiazem and verapamil, as they can worsen heart failure in patients with hypotension 5, 8
• The European Journal of Heart Failure suggests avoiding clonidine and moxonidine in heart failure patients with hypotension, due to their potential to exacerbate hypotension 5
• The European Journal of Heart Failure recommends against using vasodilators, such as nitroglycerin, nitroprusside, and nesiritide, in patients with systolic blood pressure <90 mmHg, as they can worsen hypotension 8